Bristol-Myers Squibb Pharma EEIG
- B01 - Agentes antitrombóticos
- ISCOVER film-coated tablet 300 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- KARVEA film-coated tablet 150 mg
- KARVEA film-coated tablet 300 mg
- KARVEA film-coated tablet 75 mg
- KARVEA tablet 150 mg
- KARVEA tablet 300 mg
- KARVEA tablet 75 mg
- KARVEZIDE film-coated tablet 150 mg+12.5 mg
- KARVEZIDE film-coated tablet 300 mg+12.5 mg
- KARVEZIDE film-coated tablet 300 mg+25 mg
- KARVEZIDE tablet 150 mg+12.5 mg
- KARVEZIDE tablet 300 mg+12.5 mg
- J05 - Antivirales de uso sistémico
- REYATAZ capsule, hard 100 mg
- REYATAZ capsule, hard 150 mg
- REYATAZ capsule, hard 200 mg
- REYATAZ capsule, hard 300 mg
- L01 - Antineoplásicos
- OPDIVO concentrate for solution for infusion 100 mg/10 ml
- OPDIVO concentrate for solution for infusion 240 mg/24 ml
- OPDIVO concentrate for solution for infusion 40 mg/4 ml
- SPRYCEL film-coated tablet 20 mg
- SPRYCEL film-coated tablet 50 mg
- SPRYCEL film-coated tablet 70 mg
- VIDAZA powder for suspension for injection 100 mg
- YERVOY concentrate for solution for infusion 200 mg/40 ml
- YERVOY concentrate for solution for infusion 50 mg/10 ml
- L04 - Inmunosupresores
- NULOJIX powder for solution for infusion 250 mg
- ORENCIA powder for solution for infusion 250 mg
- ZEPOSIA capsule, hard 0.23 mg
- ZEPOSIA capsule, hard 0.46 mg
- ZEPOSIA capsule, hard 0.92 mg
- V08 - Medios de contraste
- LUMINITY solution for injection 225 µl/1.5 ml